SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

NCT00307047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3687

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: XIENCE V® Everolimus Eluting Coronary Stent
DEVICE: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent

Sponsor

Abbott Medical Devices